Predicting progression to Alzheimer’s disease from clinical and imaging data: a reproducible study - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Conference Papers Year :

Predicting progression to Alzheimer’s disease from clinical and imaging data: a reproducible study

Abstract

Various machine learning approaches have been developed for predicting progression to Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI) from MRI and PET data. Objective comparison of these approaches is nearly impossible because of differences at all steps, from data management to image processing and evaluation procedures. Moreover, with a few exceptions, these papers rarely compare their results to that obtained with clinical/cognitive data only, a critical point to demonstrate the practical utility of neuroimaging in this context. We previously proposed a framework for the reproducible evaluation of ML algorithms for AD classification. This framework was applied to AD classification using unimodal neuroimaging data (T1 MRI and FDG PET). Here, we extend our previous work to the combination of multimodal clinical and neuroimaging data for predicting progression to AD among MCI patients. All the code is publicly available at: https://github.com/aramis-lab/AD-ML.
Fichier principal
Vignette du fichier
OHBM Jorge .pdf (548.09 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02142315 , version 1 (28-05-2019)

Identifiers

  • HAL Id : hal-02142315 , version 1

Cite

Jorge Samper-Gonzalez, Ninon Burgos, Simona Bottani, Marie-Odile Habert, Theodoros Evgeniou, et al.. Predicting progression to Alzheimer’s disease from clinical and imaging data: a reproducible study. OHBM 2019 - Organization for Human Brain Mapping Annual Meeting 2019, Jun 2019, Rome, Italy. ⟨hal-02142315⟩
273 View
209 Download

Share

Gmail Facebook Twitter LinkedIn More